Taking IBD Genes from GWAS to Function to Drug Target Ghent University
Inflammatory bowel disease (IBD), mainly represented by Crohn’s disease and ulcerative colitis, affects ~1/300 people in Western societies and is increasing all over the world. The risk to develop IBD varies between individuals and is in part determined by genetics. Genome Wide Association Studies (GWAS) have revealed specific risk loci in our genome and indicated many candidate causative genes for IBD. Moreover, they have potential to ...